Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Laboratorios Farmaceuticos ROVI, S.A. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Laboratorios Farmaceuticos ROVI, S.A. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Laboratorios Farmindustria S.A. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Laboratorios Farmindustria S.A. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Lactose (India) Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Lactose (India) Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Lannett Company, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Lannett Company, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Lansen Pharmaceutical Holdings Co., Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Lansen Pharmaceutical Holdings Co., Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Lavipharm SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Lavipharm SA Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Layerlab AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Layerlab AB Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Lee's Pharmaceutical Holdings Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Lee's Pharmaceutical Holdings Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Lescarden Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Lescarden Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Lexicon Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Lexicon Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

LG Life Sciences Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

LG Life Sciences Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Life Nutrition Products, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Life Nutrition Products, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Life Technologies Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Life Technologies Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Veloxis Pharmaceuticals A/S Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Veloxis Pharmaceuticals A/S Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

LifeHealthCare Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

LifeHealthCare Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Lifevantage Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Lifevantage Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ligand Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ligand Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Lightlake Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Lightlake Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Lijun International Pharmaceutical (Holding) Co Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Lijun International Pharmaceutical (Holding) Co Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Lincoln Pharmaceuticals Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Lincoln Pharmaceuticals Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Linical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Linical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

LipidViro Tech Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

LipidViro Tech Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Living Cell Technologies Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Living Cell Technologies Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Livzon Pharmaceutical Group Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Livzon Pharmaceutical Group Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Lixte Biotechnology Holdings, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Lixte Biotechnology Holdings, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Long-e International, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Long-e International, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Lonza Group AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Lonza Group AG Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 128 pages

Lorus Therapeutics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Lorus Therapeutics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Lotus Pharmaceutical Co Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Lotus Pharmaceutical Co Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Lotus Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Lotus Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Apollo Endosurgery, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Apollo Endosurgery, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

LTT Bio-Pharma Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

LTT Bio-Pharma Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Luminex Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Luminex Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Luna Innovations Incorporated Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Luna Innovations Incorporated Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Lupin Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Lupin Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Luye Pharma Group Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Luye Pharma Group Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Lyka Labs Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Lyka Labs Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

MabCure, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

MabCure, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Mabion SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Mabion SA Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Macrogen Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Macrogen Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Makers Laboratories Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Makers Laboratories Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Malaysian Genomics Resource Centre Berhad Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Malaysian Genomics Resource Centre Berhad Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Manchester International Holdings Unlimited Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Manchester International Holdings Unlimited Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Mangalam Drugs & Organics Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Mangalam Drugs & Organics Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Manhattan Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Manhattan Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

MannKind Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

MannKind Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

MAP Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

MAP Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Marina Biotech, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Marina Biotech, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Marksans Pharma Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Marksans Pharma Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Marshall Edwards Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Marshall Edwards Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1